Literature DB >> 849651

Macrophage responses to mouldy hay dust, Micropolyspora faeni and zymosan, activators of complement by the alternative pathway.

H U Schorlemmer, J H Edwards, P Davies, A C Allison.   

Abstract

Mouse peritoneal macrophages in culture exposed to mouldy hay dust, Micropolyspora faeni or glycopeptide or protein/glycoprotein fractions from this organism show marked biochemical changes. For comparison the interaction of cultured macrophages with zymosan has been investigated. All these agents induce the release of hydrolytic enzymes from macrophages, even in the absence of serum in the medium. The release is time- and dose-dependent and is not associated with loss of the cytoplasmic enzyme lactate dehydrogenase or any other sign of cell death. The parallelism between the capacity of these agents to activate the complement system via the alternative pathway and to induce inflammatory responses in vivo and selective lysosomal enzyme secretion from cultures of macrophages is discussed. The in vitro phenomena seen with mouldy hay dust, M. faeni, the protein/glycoprotein and the glycopeptide derived from it, may be relevant to understanding the role of mononuclear phagocytes in the disease farmer's lung and other inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849651      PMCID: PMC1540791     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  ISOLATION OF THE CAUSATIVE AGENT OF FARMER'S LUNG.

Authors:  F WENZEL; D A EMANUEL; B R LAWTON; G E MAGNIN
Journal:  Ann Allergy       Date:  1964-10

2.  Mammalian glycosidases; distribution in the body.

Authors:  J CONCHIE; J FINDLAY; G A LEVVY
Journal:  Biochem J       Date:  1959-02       Impact factor: 3.857

3.  Effects of activated complement components on enzyme secretion by macrophages.

Authors:  H U Schorlemmer; A C Allison
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

4.  Interaction of C3b, B, and D in the alternative pathway of complement activation.

Authors:  A Nicholson; V Brade; H U Schorlemmer; R Burger; D Bitter-Suermann; U Hadding
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

5.  Effect of cyclic AMP on release of lysosomal enzymes from phagocytes.

Authors:  G Weissmann; P Dukor; R B Zurier
Journal:  Nat New Biol       Date:  1971-06-02

6.  Further studies on the chemotactic factor of complement and its formation in vivo.

Authors:  P A Ward; C G Cochrane; H J Muller-Eberhard
Journal:  Immunology       Date:  1966-08       Impact factor: 7.397

7.  Hypothesis. Bound C3 as the second signal for B-cell activation.

Authors:  P Dukor; K U Hartmann
Journal:  Cell Immunol       Date:  1973-06       Impact factor: 4.868

8.  Hypersensitivity pneumonitis: experimental production in guinea pigs with antigens of Micropolyspora faeni.

Authors:  B Wilkie; B Pauli; M Gygax
Journal:  Pathol Microbiol (Basel)       Date:  1973

9.  In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages.

Authors:  C Bentley; D Bitter-Suermann; U Hadding; V Brade
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

10.  Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance.

Authors:  P Davies; R C Page; A C Allison
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  20 in total

1.  The selective release of lysosomal acid hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation.

Authors:  H U Schorlemmer; P Davies; W Hylton; M Gugig; A C Allison
Journal:  Br J Exp Pathol       Date:  1977-06

Review 2.  Polyclonal activators in pulmonary immune disease.

Authors:  W F Willoughby; J B Willoughby; G F Gerberick
Journal:  Clin Rev Allergy       Date:  1985-05

3.  Experimental farmer's lung.

Authors:  J Guo; D Y Che
Journal:  J Tongji Med Univ       Date:  1986

4.  Comparison of peritoneal macrophages from germfree and conventional mice.

Authors:  B Mørland; A I Smievoll; T Midtvedt
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

5.  Biochemical differences in the mechanism of macrophage lysosomal exocytosis initiated by zymosan particles and weak bases.

Authors:  D W Riches; J L Watkins; D R Stanworth
Journal:  Biochem J       Date:  1983-06-15       Impact factor: 3.857

6.  Degradation of cartilage proteoglycans by a neutral proteinase secreted by rabbit bone-marrow macrophages in culture.

Authors:  P Hauser; G Vaes
Journal:  Biochem J       Date:  1978-05-15       Impact factor: 3.857

7.  A macrophage-nanozyme delivery system for Parkinson's disease.

Authors:  Elena V Batrakova; Shu Li; Ashley D Reynolds; R Lee Mosley; Tatiana K Bronich; Alexander V Kabanov; Howard E Gendelman
Journal:  Bioconjug Chem       Date:  2007-08-31       Impact factor: 4.774

8.  Prostaglandins and the lung.

Authors:  J Morley
Journal:  Postgrad Med J       Date:  1977-11       Impact factor: 2.401

9.  Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. I. Development and initial characterisation of the model.

Authors:  J Dawson; C Rordorf-Adam; T Geiger; H Towbin; S Kunz; H Nguyen; O Zingel; D Chaplin; K Vosbeck
Journal:  Agents Actions       Date:  1993-03

10.  Studies on the possible involvement of complement component C3 in the initiation of acid hydrolase secretion by macrophages. I. Correlation between enzyme-releasing and complement-activating capacities of several secretagogues.

Authors:  D W Riches; D R Stanworth
Journal:  Immunology       Date:  1981-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.